Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WALANT Versus Axillary Brachial Plexus Block in Carpal Tunnel Release
NCT06040840Completed
- Sponsor
- CMC Ambroise Paré
- Start
- May 2024
- Primary completion
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of lidocaine and epinephrine in carpal tunnel syndrome (CTS) (2 arms), sponsored by CMC Ambroise Paré. Primary endpoint: Regional anesthesia success at 2 hours. Started May 2024; status: completed.
02
Drugs
lidocaineepinephrine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT06040840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06040840.